Biotech

South San Francisco, California | April 10, 2026 Allogene Therapeutics has announced that it will present the interim futility...

MELBOURNE, Australia – Nov. 26, 2025 — Neurizon Therapeutics (ASX: NUZ & NUZOA; OTCQB: NUZTF), a clinical-stage biotech firm...

Chatham, New Jersey, November 24, 2025 — Tonix Pharmaceuticals announced that the U.S. Food & Drug Administration has cleared...

ROCKVILLE, MD — November 20, 2025 — OS Therapies announced the strategic spin-off of OS Animal Health, establishing it...

SOUTH SAN FRANCISCO, Calif.,—Kezar Life Sciences has reported its second-quarter 2025 financial results alongside a notable series of regulatory...

HOUSTON, Oct. 20, 2025 – The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to...